These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 26642248)

  • 1. Prognostic use of soluble fms-like tyrosine kinase-1 and placental growth factor in patients with coronary artery disease.
    Sinning C; Schnabel RB; Zeller T; Seiffert M; Rupprecht HJ; Lackner KJ; Blankenberg S; Bickel C; Westermann D
    Biomark Med; 2016; 10(1):95-106. PubMed ID: 26642248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
    Matsumoto T; Uemura S; Takeda Y; Matsui M; Okada S; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Onoue K; Kawata H; Kawakami R; Horii M; Saito Y
    Intern Med; 2013; 52(10):1019-27. PubMed ID: 23676585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure.
    Hammadah M; Georgiopoulou VV; Kalogeropoulos AP; Weber M; Wang X; Samara MA; Wu Y; Butler J; Tang WH
    Circ Heart Fail; 2016 Jan; 9(1):e002115. PubMed ID: 26699385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia.
    Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Escribano D; Denk B; Galindo A
    Ultrasound Obstet Gynecol; 2014 May; 43(5):525-32. PubMed ID: 24185845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction.
    Hochholzer W; Reichlin T; Stelzig C; Hochholzer K; Meissner J; Breidthardt T; Reiter M; Duehsler B; Freidank H; Winkler K; Twerenbold R; Mueller C
    Eur Heart J; 2011 Feb; 32(3):326-35. PubMed ID: 21138939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
    Kodama Y; Kitta Y; Nakamura T; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
    J Am Coll Cardiol; 2006 Jul; 48(1):43-50. PubMed ID: 16814647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal soluble fms-like tyrosine kinase-1, placental growth factor, plasminogen activator inhibitor-2, and folate concentrations and early fetal size: the Generation R study.
    Bouwland-Both MI; Steegers EA; Lindemans J; Russcher H; Hofman A; Geurts-Moespot AJ; Sweep FC; Jaddoe VW; Steegers-Theunissen RP
    Am J Obstet Gynecol; 2013 Aug; 209(2):121.e1-11. PubMed ID: 23583216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of maternal serum angiogenic factors in third-trimester normal pregnancies: reference ranges, influence of maternal and pregnancy factors and fetoplacental Doppler indices.
    Lobmaier SM; Figueras F; Mercade I; Crovetto F; Peguero A; Parra-Saavedra M; Ortiz JU; Crispi F; Gratacós E
    Fetal Diagn Ther; 2014; 36(1):38-43. PubMed ID: 24903330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
    Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
    Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia.
    van Helden J; Weiskirchen R
    Clin Biochem; 2015 Nov; 48(16-17):1113-9. PubMed ID: 26129879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble FMS-like tyrosine kinase-1 (sFlt-1) and serum placental growth factor (PlGF) as biomarkers for ectopic pregnancy and missed abortion.
    Daponte A; Pournaras S; Polyzos NP; Tsezou A; Skentou H; Anastasiadou F; Lialios G; Messinis IE
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1444-51. PubMed ID: 21715541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.
    Ky B; French B; Ruparel K; Sweitzer NK; Fang JC; Levy WC; Sawyer DB; Cappola TP
    J Am Coll Cardiol; 2011 Jul; 58(4):386-94. PubMed ID: 21757116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study.
    Bergen NE; Bouwland-Both MI; Steegers-Theunissen RP; Hofman A; Russcher H; Lindemans J; Jaddoe VW; Steegers EA
    Hum Reprod; 2015 Jun; 30(6):1302-13. PubMed ID: 25854264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
    Forest JC; Thériault S; Massé J; Bujold E; Giguère Y
    Clin Chem Lab Med; 2014 Aug; 52(8):1169-78. PubMed ID: 24535301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of small-for-gestational-age neonates: screening by placental growth factor and soluble fms-like tyrosine kinase-1 at 35-37 weeks.
    Fadigas C; Peeva G; Mendez O; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Aug; 46(2):191-7. PubMed ID: 25825848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia.
    Ohkuchi A; Hirashima C; Matsubara S; Takahashi K; Matsuda Y; Suzuki M
    Hypertension; 2011 Nov; 58(5):859-66. PubMed ID: 21947468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating angiogenic factors and placental abruption.
    Signore C; Mills JL; Qian C; Yu K; Lam C; Epstein FH; Karumanchi SA; Levine RJ
    Obstet Gynecol; 2006 Aug; 108(2):338-44. PubMed ID: 16880304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.